Ranolazine Among Unrevascularized Chronic Stable Angina Patients
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This is a prospective, double-blind, placebo-controlled, randomized, single-center (North
Florida- South Georgia VA Medical Center) study. The study objective is to determine if
ranolazine improves angina symptoms at 4 months compared with placebo among stable coronary
artery disease patients who have demonstrable myocardial ischemia, but who do not undergo
revascularization
Phase:
Phase 2
Details
Lead Sponsor:
North Florida Foundation for Research and Education